1 Background Intraventricular hemorrhage (IVH), particularly in extremely preterm infants (i.e., born at <28 gestational weeks), presents a significant clinical challenge with lasting neurological consequences.[1, 2] It affects up to 20% of extremely preterm newborns, and despite advancements in neonatal care, IVH remains a leading cause of morbidity and mortality in neonatal intensive care units.[2] ≈50% of extremely preterm survivors of IVH are at risk of developing cerebral palsy or...
